Telix Pharmaceuticals Ltd - TLX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 06, 2026 | MD & Group CEO | P | A | 33,435.0 | 14.87 | 497,178.45 | 20,742,935.0 | View | |
| May 06, 2026 | MD & Group CEO | P | A | 34,500.0 | 14.48 | 499,560.0 | 20,709,500.0 | View | |
| Apr 01, 2026 | Group Chief Financial Officer | M | D | 1,111.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Group Chief Financial Officer | M | A | 1,111.0 | 0.0 | 0.0 | 11,921.0 | View |